Meredith Sigler

Meredith Sigler, PharmD, serves as an Assistant Professor in the Department of Pharmacy Practice at Texas Tech University Health Sciences Center's Jerry H. Hodge School of Pharmacy since 2015. She practices clinically at the VA North Texas Health Care System as a Congestive Heart Failure Clinic specialist, holding board certification in pharmacotherapy.

Her educational background includes a PharmD from Texas Tech University Health Sciences Center School of Pharmacy (2013), BS from the University of Oklahoma (2008), and PGY1/PGY2 ambulatory care residencies at the Medical University of South Carolina (2015).

Dr. Sigler's research centers on heart failure management, cardiovascular disease, and health disparities, with significant focus on cardiometabolic risk reduction and chronic disease state management. Her work bridges clinical pharmacy practice with health equity research, particularly examining treatment outcomes in veteran populations.

Analysis of her 15 publications (2013-2024) reveals dominant themes in heart failure pharmacotherapy, SGLT2 inhibitor applications for diabetes-heart failure comorbidity, and racial outcome disparities. Her work spans cardiology, endocrinology, and health services research, demonstrating consistent focus on evidence-based interventions for complex chronic conditions.

Scientific recognition includes:

• VA North Texas PGY2 Ambulatory Care Preceptor of the Year (2022)
• Dallas Faculty Preceptor of the Year (2022)
• TTUHSC Office of Sciences Internal Seed Grant (2021)

Dr. Sigler precepts pharmacy students and PGY2 residents in heart failure rotations while leading the Advanced Cardiology elective. Her grant-funded research examines cardiometabolic management in veterans, reflecting strong integration of clinical practice and academic mentorship.

She actively collaborates within the VA North Texas Heart Failure Clinic's interdisciplinary team, driving initiatives in medication optimization and health disparity reduction for high-risk cardiac patients.